FLGT logo

Fulgent Genetics (FLGT) CAPEX

Annual CAPEX

$22.21 M
-$6.57 M-22.83%

December 31, 2023

Summary

Performance

1-Year Change

-22.83%

3-Year Change

-36.79%

5-Year Change

+684.15%

15-Year Change

+314.62%

FLGT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.87%
FLGT annual capital expenditures is higher than 73.87% of companies in Healthcare sector

High & Low

All-time High

$35.13 M
FLGT annual capital expenditures is currently -36.79% below its historical high of $35.13 million

3-Year Low

$22.21 M
FLGT annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
FLGT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
FLGT next annual earnings announcement is scheduled for Feb 28, 2025

OtherFLGTcash flowmetrics:

Annual FCF

$4.80 M
FLGT annual free cash flow is $4.80 million

Annual CFO

$27.00 M
FLGT annual cash flow from operations is $27.00 million

Annual CFI

$38.90 M
FLGT annual cash flow from investing activities is $38.90 million

Annual CFF

-$47.78 M
FLGT annual cash flow from financing activities is -$47.78 million

Quarterly CAPEX

$19.54 M
+$6.59 M+50.93%

September 30, 2024

Summary

Performance

3-Month Change

+50.93%

1-Year Change

+296.85%

3-Year Change

+32.71%

5-Year Change

+32.71%

FLGT Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.99%
FLGT quarterly capital expenditures is higher than 85.99% of companies in Healthcare sector

High & Low

All-time High

$23.79 M
FLGT quarterly capital expenditures is currently -17.89% below its historical high of $23.79 million

3-Year Low

$2.03 M
FLGT quarterly capital expenditures is currently +860.52% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FLGT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FLGT next earnings announcement is scheduled for Feb 28, 2025

OtherFLGTcash flowmetrics:

Quarterly FCF

-$35.05 M
FLGT quarterly free cash flow is -$35.05 million

Quarterly CFO

-$15.51 M
FLGT quarterly cash flow from operations is -$15.51 million

Quarterly CFI

$8.98 M
FLGT quarterly cash flow from investing activities is $8.98 million

Quarterly CFF

-$567.00 K
FLGT quarterly cash flow from financing activities is -$567.00 thousand

TTM CAPEX

$39.64 M
+$14.61 M+58.39%

September 30, 2024

Summary

Performance

3-Month Change

+58.39%

1-Year Change

+17.21%

3-Year Change

+37.77%

5-Year Change

+37.77%

FLGT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

79.97%
FLGT TTM capital expenditures is higher than 79.97% of companies in Healthcare sector

High & Low

All-time High

$48.35 M
FLGT TTM capital expenditures is currently -18.01% below its historical high of $48.35 million

3-Year Low

$17.71 M
FLGT TTM capital expenditures is currently +123.82% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FLGT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FLGT next earnings announcement is scheduled for Feb 28, 2025

OtherFLGTcash flowmetrics:

TTM FCF

-$28.67 M
FLGT TTM free cash flow is -$28.67 million

TTM CFO

$10.97 M
FLGT TTM cash flow from operations is $10.97 million

TTM CFI

-$6.63 M
FLGT TTM cash flow from investing activities is -$6.63 million

TTM CFF

-$30.47 M
FLGT TTM cash flow from financing activities is -$30.47 million

FLGT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-22.8%+296.9%+17.2%
3 y3 years-36.8%+32.7%+37.8%
5 y5 years+684.1%+32.7%+37.8%

FLGT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.8%at lowat high+860.5%at high+123.8%
5 y5-year-36.8%+1778.8%-17.9%+4653.5%-18.0%+3253.9%
alltimeall time-36.8%+2937.9%-17.9%>+9999.0%-18.0%>+9999.0%

Fulgent Genetics CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$19.54 M(+50.9%)
$39.64 M(+58.4%)
Jun 2024
-
$12.94 M(+219.1%)
$25.03 M(+3.3%)
Mar 2024
-
$4.06 M(+30.6%)
$24.23 M(+9.1%)
Dec 2023
$22.21 M(-22.8%)
$3.11 M(-36.9%)
$22.21 M(-34.3%)
Sep 2023
-
$4.92 M(-59.5%)
$33.82 M(-1.5%)
Jun 2023
-
$12.14 M(+497.1%)
$34.34 M(+34.9%)
Mar 2023
-
$2.03 M(-86.2%)
$25.45 M(-11.6%)
Dec 2022
$28.77 M(+20.7%)
$14.72 M(+170.9%)
$28.77 M(+43.4%)
Sep 2022
-
$5.43 M(+66.8%)
$20.07 M(+11.3%)
Jun 2022
-
$3.26 M(-39.2%)
$18.04 M(+1.8%)
Mar 2022
-
$5.36 M(-10.9%)
$17.71 M(-25.7%)
Dec 2021
$23.84 M(-32.1%)
$6.01 M(+76.8%)
$23.84 M(-42.7%)
Sep 2021
-
$3.40 M(+15.9%)
$41.62 M(-13.9%)
Jun 2021
-
$2.94 M(-74.5%)
$48.35 M(+5.5%)
Mar 2021
-
$11.49 M(-51.7%)
$45.83 M(+30.4%)
Dec 2020
$35.13 M
$23.79 M(+134.9%)
$35.13 M(+197.8%)
Sep 2020
-
$10.13 M(+2364.5%)
$11.80 M(+571.8%)
Jun 2020
-
$411.00 K(-48.4%)
$1.76 M(-4.8%)
DateAnnualQuarterlyTTM
Mar 2020
-
$796.00 K(+72.7%)
$1.84 M(+56.0%)
Dec 2019
$1.18 M(-58.3%)
$461.00 K(+423.9%)
$1.18 M(+40.0%)
Sep 2019
-
$88.00 K(-82.4%)
$844.00 K(-53.2%)
Jun 2019
-
$499.00 K(+272.4%)
$1.80 M(-2.5%)
Mar 2019
-
$134.00 K(+8.9%)
$1.85 M(-34.7%)
Dec 2018
$2.83 M(-47.1%)
$123.00 K(-88.3%)
$2.83 M(-26.4%)
Sep 2018
-
$1.05 M(+91.8%)
$3.85 M(-30.0%)
Jun 2018
-
$546.00 K(-51.1%)
$5.50 M(-13.8%)
Mar 2018
-
$1.12 M(-2.2%)
$6.38 M(+19.2%)
Dec 2017
$5.36 M(+41.4%)
$1.14 M(-57.7%)
$5.36 M(+15.8%)
Sep 2017
-
$2.70 M(+89.1%)
$4.62 M(-2.5%)
Jun 2017
-
$1.43 M(+1485.6%)
$4.74 M(+28.1%)
Mar 2017
-
$90.00 K(-78.0%)
$3.70 M(-2.3%)
Dec 2016
$3.79 M(+80.4%)
$409.00 K(-85.5%)
$3.79 M(+12.1%)
Sep 2016
-
$2.82 M(+629.5%)
$3.38 M(+500.2%)
Jun 2016
-
$386.00 K(+118.1%)
$563.00 K(+218.1%)
Mar 2016
-
$177.00 K
$177.00 K
Dec 2015
$2.10 M(+187.3%)
-
-
Dec 2014
$731.00 K
-
-

FAQ

  • What is Fulgent Genetics annual capital expenditures?
  • What is the all time high annual CAPEX for Fulgent Genetics?
  • What is Fulgent Genetics annual CAPEX year-on-year change?
  • What is Fulgent Genetics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Fulgent Genetics?
  • What is Fulgent Genetics quarterly CAPEX year-on-year change?
  • What is Fulgent Genetics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Fulgent Genetics?
  • What is Fulgent Genetics TTM CAPEX year-on-year change?

What is Fulgent Genetics annual capital expenditures?

The current annual CAPEX of FLGT is $22.21 M

What is the all time high annual CAPEX for Fulgent Genetics?

Fulgent Genetics all-time high annual capital expenditures is $35.13 M

What is Fulgent Genetics annual CAPEX year-on-year change?

Over the past year, FLGT annual capital expenditures has changed by -$6.57 M (-22.83%)

What is Fulgent Genetics quarterly capital expenditures?

The current quarterly CAPEX of FLGT is $19.54 M

What is the all time high quarterly CAPEX for Fulgent Genetics?

Fulgent Genetics all-time high quarterly capital expenditures is $23.79 M

What is Fulgent Genetics quarterly CAPEX year-on-year change?

Over the past year, FLGT quarterly capital expenditures has changed by +$14.61 M (+296.85%)

What is Fulgent Genetics TTM capital expenditures?

The current TTM CAPEX of FLGT is $39.64 M

What is the all time high TTM CAPEX for Fulgent Genetics?

Fulgent Genetics all-time high TTM capital expenditures is $48.35 M

What is Fulgent Genetics TTM CAPEX year-on-year change?

Over the past year, FLGT TTM capital expenditures has changed by +$5.82 M (+17.21%)